News Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
5.9 ^CNY	+2.97%		+7.27%	-26.16%

Apr. 25	Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Guangji Pharmaceutical Gets Nod to Produce Entecavir	Nov. 07	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Guangji Pharma to Establish Joint Innovation Laboratory With Jiangnan University	23-06-15	MT
Guangji Pharma to Borrow 281 Million Yuan From Bank to Support Acquisition Deals	23-05-17	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Hubei Guangji Pharmaceutical Announces Profit Distribution Proposal for 2022	23-04-20	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Guangji Pharma Registers Diabetes-Related Infection Drug	23-03-29	MT
Hubei Guangji Pharma to Invest 468 Million Yuan in Parkson Biotechnology Amid Bankruptcy Reorganization	23-02-08	MT
Hubei Guangji Pharma Signs 6MW Solar Power Project	22-12-15	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage	22-10-04	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18	CI
Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced that it has received CNY 45 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.	22-07-18	CI
Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022	22-05-19	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Hubei Guangji Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	22-04-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

Summary

Filters